Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul:153:196-204.
doi: 10.1016/j.bcp.2018.02.020. Epub 2018 Feb 16.

Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics

Affiliations
Review

Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics

Taha Ahmad et al. Biochem Pharmacol. 2018 Jul.

Abstract

Methadone is a synthetic, long-acting opioid with a single chiral center forming two enantiomers, (R)-methadone and (S)-methadone, each having specific pharmacological actions. Concentrations of (R)- and (S)-methadone above therapeutic levels have the ability to cause serious, life-threatening, and fatal side effects. This toxicity can be due in part to the pharmacogenetics of an individual, which influences the pharmacokinetic and pharmacodynamic properties of the drug. Methadone is primarily metabolized in the liver by cytochrome P450 (CYP) enzymes, predominately by CYP2B6, followed by CYP3A4, 2C19, 2D6, and to a lesser extent, CYP2C18, 3A7, 2C8, 2C9, 3A5, and 1A2. Single nucleotide polymorphisms (SNPs) located within CYPs have the potential to play an important role in altering methadone metabolism and pharmacodynamics. Several SNPs in the CYP2B6, 3A4, 2C19, 2D6, and 3A5 genes result in increases in methadone plasma concentrations, decreased N-demethylation, and decreased methadone clearance. In particular, carriers of CYP2B6*6/*6 may have a greater risk for detrimental adverse effects, as methadone metabolism and clearance are diminished in these individuals. CYP2B6*4, on the other hand, has been observed to decrease plasma concentrations of methadone due to increased methadone clearance. The involvement, contribution, and understanding the role of SNPs in CYP2B6, and other CYP genes, in methadone metabolism can improve the therapeutic uses of methadone in patient outcome and the development of personalized medicine.

Keywords: Cytochrome P450 (CYP); Genetic variant; Methadone metabolism; Pharmacogenetics; Single nucleotide polymorphism (SNP).

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Eleven methadone metabolites found in human excretion. *Indicates chiral carbon atom. ADH, alcohol dehydrogenase; CYP, cytochrome P450; EDDP, 2-ethyl-1,5-dimethyl-3,3-diphenylpyrrolidine; EMDP, 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline; p-HO, para-hydroxy.

References

    1. Rettig R, Yarmolinsky A, Executive Summary. Institute of Medicine, Federal Regulation of Methadone Treatment, The National Academies Press, Washington, DC, 1995, p. 1,, http://dx.doi.org/10.17226/4899. - DOI - PubMed
    1. Dole VP, Nyswander M, A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride, JAMA 23 (1965) 646–650, 10.1001/jama.1965.03090080008002. - DOI - PubMed
    1. Joseph H, Stancliff S, Langord J, Methadone maintenance treatment (MMT): a review of historical and clinical issues, Mt Sinai J. Med 67 (2000) 347–364. - PubMed
    1. Drucker E, Lurie P, Wodakt A, Alcabes P, Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV, AIDS 12 (Suppl. A) (1998) S217–S230. - PubMed
    1. Somogyi AA, Barratt DT, Ali RL, Coller JK, Pharmacogenomics of methadone maintenance treatment, Pharmacogenomics 15 (2014) 1007–1027, 10.2217/pgs.14.56. - DOI - PubMed

Publication types

MeSH terms